568 Shares in Stryker Co. (NYSE:SYK) Purchased by Wealth Advisors Northwest LLC

Wealth Advisors Northwest LLC bought a new stake in Stryker Co. (NYSE:SYK) during the fourth quarter, HoldingsChannel.com reports. The fund bought 568 shares of the medical technology company’s stock, valued at approximately $205,000.

Several other hedge funds also recently modified their holdings of SYK. Exchange Traded Concepts LLC boosted its position in Stryker by 1.9% during the third quarter. Exchange Traded Concepts LLC now owns 5,261 shares of the medical technology company’s stock worth $1,901,000 after acquiring an additional 96 shares during the last quarter. Koshinski Asset Management Inc. lifted its stake in shares of Stryker by 4.0% during the 3rd quarter. Koshinski Asset Management Inc. now owns 2,403 shares of the medical technology company’s stock worth $868,000 after purchasing an additional 92 shares during the period. Grove Bank & Trust boosted its holdings in shares of Stryker by 84.8% during the third quarter. Grove Bank & Trust now owns 122 shares of the medical technology company’s stock worth $44,000 after purchasing an additional 56 shares during the last quarter. CX Institutional grew its position in shares of Stryker by 3.9% in the third quarter. CX Institutional now owns 3,478 shares of the medical technology company’s stock valued at $1,257,000 after purchasing an additional 130 shares during the period. Finally, Wesbanco Bank Inc. increased its stake in Stryker by 5.7% in the third quarter. Wesbanco Bank Inc. now owns 26,172 shares of the medical technology company’s stock valued at $9,455,000 after purchasing an additional 1,401 shares during the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the transaction, the director now owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 5.90% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on SYK. Barclays raised their price target on Stryker from $418.00 to $443.00 and gave the stock an “overweight” rating in a research note on Monday. Truist Financial raised their target price on shares of Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a research report on Thursday, January 30th. The Goldman Sachs Group upped their price target on shares of Stryker from $384.00 to $427.00 and gave the stock a “neutral” rating in a research report on Thursday, January 30th. Canaccord Genuity Group lifted their price target on shares of Stryker from $420.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Finally, Evercore ISI boosted their price objective on shares of Stryker from $380.00 to $384.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $420.68.

Stryker Stock Performance

Shares of NYSE:SYK opened at $390.52 on Wednesday. The business’s 50-day simple moving average is $377.28 and its 200 day simple moving average is $365.59. The company has a market cap of $148.88 billion, a P/E ratio of 50.33, a PEG ratio of 2.98 and a beta of 0.96. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. Stryker Co. has a one year low of $314.93 and a one year high of $406.19.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, topping analysts’ consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter in the previous year, the company earned $3.46 EPS. On average, sell-side analysts forecast that Stryker Co. will post 13.49 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be given a $0.84 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. Stryker’s payout ratio is currently 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.